Essential mixed cryoglobulinemia type III with leukocytoclastic vasculitis: remission by rituximab. [electronic resource]
Producer: 20130903Description: S19-20 p. digitalISSN:- 1434-9949
- Adult
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Cryoglobulinemia -- complications
- Cyclophosphamide -- therapeutic use
- Drug Substitution
- Drug Therapy, Combination
- Female
- Glucocorticoids -- therapeutic use
- Humans
- Immunologic Factors -- therapeutic use
- Pulse Therapy, Drug
- Remission Induction
- Rituximab
- Treatment Outcome
- Vasculitis, Leukocytoclastic, Cutaneous -- complications
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.